Loading clinical trials...
Loading clinical trials...
''(COVID-19) and Anxiety and Depressive Symptoms in Pregnant Women"
In our study; Anxiety and depression levels, socio-demographic characteristics of the pregnant women who were admitted to our hospital between 25.04.2020-25.07.2020 and treated with the diagnosis of covid 19, and the change in anxiety and depression levelsWİTH Beck Depression and Anxiety Score after the disease regressed are planned. (Beck depression scale contains 10 questions and a total of 1 to 100 points is obtained. High score indicates that depression and anxiety are high.) 0-16 points = mild depressive symptoms 17-29 points = moderate depressive symptoms 30-63 points = severe depressive symptoms
The sociodemographic data form prepared by the researchers will be filled out by interviewing the patients who are willing to participate in the study. In addition, Beck Depression Scale, Beck Anxiety Scale, State and Trait Anxiety Scale will be given by the participants themselves. When the patients come to their first control after discharge, the scales specified will be repeated.
Age
18 - 45 years
Sex
FEMALE
Healthy Volunteers
Yes
Pinar Yalcin Bahat
Istanbul, İ̇stanbul, Turkey (Türkiye)
Start Date
April 25, 2020
Primary Completion Date
August 25, 2020
Completion Date
August 26, 2020
Last Updated
September 2, 2020
100
ACTUAL participants
covid-19 positive pregnant women
BEHAVIORAL
Lead Sponsor
Kanuni Sultan Suleyman Training and Research Hospital
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT06082518